Deferred Tax Assets, Valuation Allowance of ENZON PHARMACEUTICALS, INC. from 31 Dec 2011 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
ENZON PHARMACEUTICALS, INC. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2011 to 31 Dec 2025.
  • ENZON PHARMACEUTICALS, INC. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $29,709,000, a 8.3% decline year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

ENZON PHARMACEUTICALS, INC. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $29,709,000 -$2,683,000 -8.3% 31 Dec 2025 10-K 02 Mar 2026 2025 FY
Q4 2024 $32,392,000 -$1,667,000 -4.9% 31 Dec 2024 10-K 02 Mar 2026 2025 FY
Q4 2023 $34,059,000 -$2,136,000 -5.9% 31 Dec 2023 10-K 21 Feb 2025 2024 FY
Q4 2022 $36,195,000 -$1,115,000 -3% 31 Dec 2022 10-K 20 Mar 2024 2023 FY
Q4 2021 $37,310,000 -$883,000 -2.3% 31 Dec 2021 10-K 16 Feb 2023 2022 FY
Q4 2020 $38,193,000 -$672,000 -1.7% 31 Dec 2020 10-K 25 Feb 2022 2021 FY
Q4 2019 $38,865,000 -$142,000 -0.36% 31 Dec 2019 10-K 23 Feb 2021 2020 FY
Q4 2018 $39,007,000 -$2,332,000 -5.6% 31 Dec 2018 10-K 19 Feb 2020 2019 FY
Q4 2017 $41,339,000 -$14,549,000 -26% 31 Dec 2017 10-K 21 Feb 2019 2018 FY
Q4 2016 $55,888,000 -$680,000 -1.2% 31 Dec 2016 10-K 21 Mar 2018 2017 FY
Q1 2016 $1,028,000 -$1,472,000 -59% 31 Mar 2016 10-Q 09 May 2016 2016 Q1
Q4 2015 $56,568,000 -$20,326,000 -26% 31 Dec 2015 10-K 24 Mar 2017 2016 FY
Q3 2015 $1,780,000 30 Sep 2015 10-Q 10 Nov 2016 2016 Q3
Q2 2015 $1,780,000 30 Jun 2015 10-Q 10 Nov 2016 2016 Q3
Q1 2015 $2,500,000 31 Mar 2015 10-Q 10 Nov 2016 2016 Q3
Q4 2014 $76,894,000 -$18,041,000 -19% 31 Dec 2014 10-K 21 Mar 2016 2015 FY
Q4 2013 $94,935,000 -$7,128,000 -7% 31 Dec 2013 10-K 05 Mar 2015 2014 FY
Q4 2012 $102,063,000 -$5,302,000 -4.9% 31 Dec 2012 10-K 14 Mar 2014 2013 FY
Q4 2011 $107,365,000 31 Dec 2011 10-K 18 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.